Vabysmo 120 mg/mL solution for injection
MR45638
Approved small_molecule active
Quick answer
Vabysmo 120 mg/mL solution for injection for Neovascular Age-Related Macular Degeneration is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Neovascular Age-Related Macular Degeneration
- Phase
- Approved
- Modality
- small_molecule
- Status
- active